Neuland Laboratories Limited is a prominent pharmaceutical company based in Hyderabad, India, founded in 1984. Here's a detailed overview of what they do and why they matter:
🧪 What Neuland Laboratories Specializes In
- Active Pharmaceutical Ingredients (APIs): They manufacture complex APIs used in various therapeutic areas.
- CDMO Services: As a Contract Development and Manufacturing Organization, Neuland supports drug development from early stages (pre-IND) to commercial production.
- Peptide Development: They offer peptide synthesis and manufacturing services at various scales.
- Custom Manufacturing Solutions: Tailored chemical synthesis, process optimization, and regulatory support for pharmaceutical and biotech companies.
🌍 Clients
- Operates in 80+ countries, including the US, Europe, Japan, and across APAC and LATAM regions.
- Serves 500+ customers, including both innovators and generic drug manufacturers.
- Facilities are US FDA, EMA, TGA, and WHO GMP certified, ensuring global regulatory compliance.
🏭 Infrastructure & Capabilities
- Three world-class manufacturing and R&D facilities.
- Over 1,700 employees, including 300+ scientists.
- Total reactor volume of 860+ KL, capable of handling diverse chemical reactions.
- A dedicated 3,400m² R&D center near Hyderabad.
📈 Market Performance & Strategy
- Neuland has seen fluctuations in stock performance, with recent rallies and dips tied to broader market trends and internal developments.
- Their Custom Manufacturing Services (CMS) segment is expected to contribute 55–60% of revenue in the next few years.
- Strategic focus includes supply chain diversification, especially as Western pharma companies reduce reliance on China.
🌱 Sustainability & Compliance
- Committed to Environmental, Social, and Governance (ESG) goals.
- Focus on process innovation, regulatory transparency, and supply chain reliability
Listen to Article:
0 Comments